These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8114969)

  • 1. [Report from abroad on side effects of drugs].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1994 Jan; 138(5):235-6. PubMed ID: 8114969
    [No Abstract]   [Full Text] [Related]  

  • 2. The international (mainly European) attitude to the drug driving problem--legislation and countermeasures.
    Irving A
    Int Clin Psychopharmacol; 1988 May; 3 Suppl 1():13-21. PubMed ID: 3403945
    [No Abstract]   [Full Text] [Related]  

  • 3. [Side effects of drugs].
    Westerholm B
    Lakartidningen; 1966 Nov; 63():Suppl 2:47-50. PubMed ID: 5979927
    [No Abstract]   [Full Text] [Related]  

  • 4. [Brief review of documents with data on the toxicity and hazards of chemical substances developed in various countries].
    Sanotskiĭ IV; Smirnova ON
    Gig Tr Prof Zabol; 1989; (3):33-6. PubMed ID: 2744552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of Academies of Medicine in the regulation of drug use].
    Valette G
    Bull Mem Acad R Med Belg; 1980; 135(9):564-72. PubMed ID: 7272528
    [No Abstract]   [Full Text] [Related]  

  • 6. [Foreign report on side effects of drugs].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1991 Nov; 135(45):2120-2. PubMed ID: 1944688
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse effects of drugs and computerized registries--a threat or a possibility?].
    Bergman U; Linnarsson R; Boethius G; Matell G; Keisu M; Peterson H; Kalles I; Wiholm BE; Krakau I; Westerholm B
    Lakartidningen; 1989 Apr; 86(16):1506-8. PubMed ID: 2725139
    [No Abstract]   [Full Text] [Related]  

  • 8. New drugs in Europe.
    De Haen P
    N Y State J Med; 1973 Mar; 73(6):777-80. PubMed ID: 4510962
    [No Abstract]   [Full Text] [Related]  

  • 9. International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(202):61134-5. PubMed ID: 16237860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [International cooperation in the recording of secondary effects of drugs. A scientific trial program pilot study of the World Health Organization].
    Homan G
    Dent Echo (Heidelb); 1968 Aug; 38(5):38-9. PubMed ID: 5246153
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adverse effects and insufficient information in Fass].
    Ekholm ML
    Lakartidningen; 2007 Jul 25-Aug 7; 104(30-31):2179. PubMed ID: 17824377
    [No Abstract]   [Full Text] [Related]  

  • 12. [Regulatory guidelines and drug safety].
    Flury W
    Ther Umsch; 1993 Jan; 50(1):49-51. PubMed ID: 8378867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Marketing of pediatric drugs].
    Pabst JY
    Soins Pediatr Pueric; 2003; (210):18-9. PubMed ID: 12683130
    [No Abstract]   [Full Text] [Related]  

  • 14. [Direct reporting of side effects by the patient: favourable experience in the first year].
    van Grootheest AC; Passier JL; van Puijenbroek EP
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):529-33. PubMed ID: 15782689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Conference on Harmonisation; guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(202):61133-4. PubMed ID: 16237859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to essential drugs.
    Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517
    [No Abstract]   [Full Text] [Related]  

  • 17. [The incidence of drug side effects with reference to organ systems. Experience of the spontaneous reporting system of the Swiss Drug Side Effect Center and Comprehensive Drug Monitoring].
    Kuhn M; Hartmann K; Maibach R; Capaul R; Gartmann JC
    Ther Umsch; 1993 Jan; 50(1):8-12. PubMed ID: 8378869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drugs and the common market].
    Myhre G
    Sygeplejersken; 1972 Mar; 72(10):12-3. PubMed ID: 4483964
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacovigilance: theoretical and practical aspects].
    Paoletti V; Galeotta G; Mammarella A
    Clin Ter; 1997 Mar; 148(3):67-73. PubMed ID: 9377842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
    Meijer WM; Cornel MC; Dolk H; de Walle HE; Armstrong NC; de Jong-van den Berg LT;
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):675-82. PubMed ID: 16761260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.